• Info
  • Significant Ownership

Significant Ownership of Medicxi IV LP

Signature - Title
/s/ Giles Johnstone-Scott - Giles Johnstone-Scott, Director of Manager
Location
St Helier, Jersey
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Medicxi IV LP.

Notify me when Medicxi IV LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Medicxi IV LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value 17% $19,446,240 22,352,000 Medicxi IV GP Limited 27 Dec 2024

Schedules 13D/G Reported by Medicxi IV LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.